Literature DB >> 35043234

Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways.

Lucia Hoppanova1, Lubica Lacinova2.   

Abstract

Noxious stimuli like cold, heat, pH change, tissue damage, and inflammation depolarize a membrane of peripheral endings of specialized nociceptive neurons which eventually results in the generation of an action potential. The electrical signal is carried along a long axon of nociceptive neurons from peripheral organs to soma located in dorsal root ganglions and further to the dorsal horn of the spinal cord where it is transmitted through a chemical synapse and is carried through the spinal thalamic tract into the brain. Two subtypes of voltage-activated calcium play a major role in signal transmission: a low voltage-activated CaV3.2 channel and a high voltage-activated CaV2.2 channel. The CaV3.2 channel contributes mainly to the signal conductance along nociceptive neurons while the principal role of the CaV2.2 channel is in the synaptic transmission at the dorsal horn. Both channels contribute to the signal initiation at peripheral nerve endings. This review summarizes current knowledge about the expression and distribution of these channels in a nociceptive pathway, the regulation of their expression and gating during pain pathology, and their suitability as targets for pharmacological therapy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CaV2.2; CaV3.2; Expression; Modulation; Neuropathic pain; Nociception

Mesh:

Year:  2022        PMID: 35043234     DOI: 10.1007/s00424-022-02666-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  132 in total

1.  Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.

Authors:  Emmanuel Bourinet; Abdelkrim Alloui; Arnaud Monteil; Christian Barrère; Brigitte Couette; Olivier Poirot; Anne Pages; John McRory; Terrance P Snutch; Alain Eschalier; Joël Nargeot
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

2.  Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.

Authors:  Catherine Abbadie; Owen B McManus; Shu-Yu Sun; Randal M Bugianesi; Ge Dai; Rodolfo J Haedo; James B Herrington; Gregory J Kaczorowski; McHardy M Smith; Andrew M Swensen; Vivien A Warren; Brande Williams; Stephen P Arneric; Cyrus Eduljee; Terrance P Snutch; Elizabeth W Tringham; Nina Jochnowitz; Annie Liang; D Euan MacIntyre; Erin McGowan; Shruti Mistry; Valerie V White; Scott B Hoyt; Clare London; Kathryn A Lyons; Patricia B Bunting; Sylvia Volksdorf; Joseph L Duffy
Journal:  J Pharmacol Exp Ther       Date:  2010-05-03       Impact factor: 4.030

3.  Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states.

Authors:  Amin Boroujerdi; Jun Zeng; Kelli Sharp; Donghyun Kim; Oswald Steward; David Z Luo
Journal:  Pain       Date:  2011-01-15       Impact factor: 6.961

4.  Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain.

Authors:  Amin Boroujerdi; Hee Kee Kim; Yeoung Su Lyu; Doo-Sik Kim; Katherine W Figueroa; Jin Mo Chung; David Z Luo
Journal:  Pain       Date:  2008-06-20       Impact factor: 6.961

5.  Differential role of N-type calcium channel splice isoforms in pain.

Authors:  Christophe Altier; Camila S Dale; Alexandra E Kisilevsky; Kevin Chapman; Andrew J Castiglioni; Elizabeth A Matthews; Rhian M Evans; Anthony H Dickenson; Diane Lipscombe; Nathalie Vergnolle; Gerald W Zamponi
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

6.  Modular, efficient synthesis of asymmetrically substituted piperazine scaffolds as potent calcium channel blockers.

Authors:  Andrey Borzenko; Hassan Pajouhesh; Jerrie-Lynn Morrison; Elizabeth Tringham; Terrance P Snutch; Laurel L Schafer
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

7.  The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin.

Authors:  Claudia S Bauer; Manuela Nieto-Rostro; Wahida Rahman; Alexandra Tran-Van-Minh; Laurent Ferron; Leon Douglas; Ivan Kadurin; Yorain Sri Ranjan; Laura Fernandez-Alacid; Neil S Millar; Anthony H Dickenson; Rafael Lujan; Annette C Dolphin
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

8.  Opioid inhibition of N-type Ca2+ channels and spinal analgesia couple to alternative splicing.

Authors:  Arturo Andrade; Sylvia Denome; Yu-Qiu Jiang; Spiro Marangoudakis; Diane Lipscombe
Journal:  Nat Neurosci       Date:  2010-09-19       Impact factor: 24.884

9.  Genetic Tracing of Cav3.2 T-Type Calcium Channel Expression in the Peripheral Nervous System.

Authors:  Yinth A Bernal Sierra; Julia Haseleu; Alexey Kozlenkov; Valérie Bégay; Gary R Lewin
Journal:  Front Mol Neurosci       Date:  2017-03-15       Impact factor: 5.639

Review 10.  Pregabalin as a Pain Therapeutic: Beyond Calcium Channels.

Authors:  Sascha R A Alles; Stuart M Cain; Terrance P Snutch
Journal:  Front Cell Neurosci       Date:  2020-04-15       Impact factor: 5.505

View more
  1 in total

Review 1.  Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain.

Authors:  Xian-Guo Liu
Journal:  J Inflamm Res       Date:  2022-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.